- Home
- Clinical Trials
Chlamydia Study Sydney DH VAV
Chlamydia Study
Darlinghurst Sydney
Did you know that more than 80% of people with chlamydia do not show any symptoms and can unknowingly spread the infection?
Did you know that chlamydia infection can lead to infertility and an increased risk of HIV?
Join a clinical research study and help researchers find a potential vaccine that may protect the sexual health of your community.
Participants will be reimbursed.
Description
What to expect
Study details
Ages
18 to 29 years old
Duration
18 months with up to 14 clinic visits
Compensation
Eligible participants will be reimbursed
Eligibility Criteria
You may qualify for this study if you:
- Are aged 18 to 29 years old AND
- Are currently sexually active and one of the following circumstances apply to you
- You have had a new sexual partner in the last 6 months
- You are not consistent with condom use
- Your sexual partner has had a previous or current STI
- You currently engage in sexual activities with more than one partner
Locations
Description
Chlamydia is the most common bacterial sexually transmitted infection (STI) worldwide. In most cases (more than 80%), people do not show symptoms and can unknowingly spread the infection. In women, untreated chlamydia can lead to serious health problems such as pelvic inflammatory disease (a major cause of infertility), ectopic pregnancy, and chronic pelvic pain. It also increases the risk of HIV infection, while in men it may cause urethritis and epididymitis.
Because current prevention methods (like using condoms and sexual education) have limited effectiveness in real-life settings, there is a need for a vaccine that can protect people against chlamydia infection.
What to expect
Momentum Clinical Research is evaluating a potential vaccine that is designed to prevent both chlamydia primary infections and reinfections. The vaccine works by using messenger RNA (mRNA) to instruct the body’s cells to produce specific proteins that stimulate an immune response that canprevent a chlamydia infection.
The aim of this study is to measure the safety, efficacy, and immune response of 3 different dosage levels and a placebo of the study vaccine. During the study, participants will receive ongoing health monitoring and
assessments.
By participating in this study, you could help contribute to the development of a vaccine that may protect the sexual health of those in your community and future generations.
Register your interest now to find out if you are eligible to participate in this clinical research study.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
*You can unsubscribe or opt out at any time.
- We collect personal information, such as your name, address and contact details, and details of your medical conditions, that enables us to identify if you may be eligible to participate in a current or future study. On occasion we may also contact people on our database by email, with general news and information relevant to our studies and volunteers. By submitting this form you agree to receive email and text notifications about this and other enrolling studies. You can unsubscribe or opt out at any time. We do not sell, share or distribute our database under any circumstances.
- We will collect this information directly from you. If you consent to release of medical records, we will obtain medical information from other agencies on your behalf if these are required for your participation in any clinical study at Momentum Clinical Research.
- Security of your information is important. Personal information collected is stored by third party data storage providers. We believe these providers offer safe and secure systems.
- All information we collect about you will be treated with confidentiality and can be accessed only by Momentum Clinical Research employees.
- By completing our online enrolment form, or any other forms we send you, you agree to us holding your personal details within our databases.
- There is no obligation for you to participate in a study that we contact you about. If you decline to participate in a study, that will not affect your eligibility for participation in another study.